L. Stribinskiene

Potentiation of etoposide-induced apoptosis by staurosporine in human tumor cells is associated with events downstream of DNA-protein complex formation

D. Sullivan, R. Lock, Bruce S. Thompson, 1997, Cancer Chemotherapy and Pharmacology.

Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival.

R. Lock, L. Stribinskiene, Richard B. Lock, 1996, Cancer research.

Expression of Bcl-2 in human epithelial tumor (HeLa) cells enhances clonogenic survival following exposure to 5-fluoro-2′-deoxyuridine or staurosporine, but not following exposure to etoposide or doxorubicin

M. Elliott, R. Lock, L. Stribinskiene, 1998, Cancer Chemotherapy and Pharmacology.

Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposide

K. Murphy, M. Elliott, R. Lock, 1999, Cancer Chemotherapy and Pharmacology.

A phase II study of radiation with concomitant and then sequential temozolomide (TMZ) in patients (pts) with newly diagnosed supratentorial high grade malignant glioma (MG) who have undergone surgery with carmustine (BCNU) wafer insertion

L. Stribinskiene, T. Vitaz, P. New, 2005 .